IONS

Ionis Pharmaceuticals Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 3/10
  • Value↓ 0/10
Ionis Pharmaceuticals sales and earnings growth
IONS Growth
Neutral
  • Revenue Y/Y↑ 33.83%
  • EPS Y/Y↑ 21.71%
  • FCF Y/Y↑ 41.41%
Ionis Pharmaceuticals gross and profit margin trends
IONS Profitability
Neutral
  • Gross margin ↑ 98.30%
  • EPS margin↓ -40.40%
  • ROIC 5Y↓ -7.62%
Ionis Pharmaceuticals net debt vs free cash flow
IONS Risk
Poor
  • Debt / Equity↑ 4.2
  • Debt / FCF↑ 5.2
  • Interest coverage↓ -3.2

Ionis Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Poor risk rating.

More Biotechnology stocks ↗